Simultaneous targeting of BH3 domain:hydrophobic groove and the TMD interface of Bcl-2 proteins, therefore, harbors not yet exploited potential for anti-cancer therapy, for example, by increasing drug specificity. This evidence concerns the gene BCL2 and cancer.